Onderzoeker
Matthias Van Woensel
- Disciplines:Biomechanica, Morfologische wetenschappen, Neurowetenschappen, Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen, Biologische en fysiologische psychologie, Cognitieve wetenschappen en intelligente systemen, Ontwikkelingspsychologie en veroudering
Affiliaties
- Onderzoeksgroep Experimentele Neurochirurgie en Neuroanatomie (Afdeling)
Lid
Vanaf1 aug 2013 → 31 jul 2020 - Aangeboren Afwijkingen in Immunologie (Labo)
Lid
Vanaf16 aug 2012 → 31 jul 2013
Projecten
1 - 1 of 1
- Evaluatie van anti-galectine-1 geneesmiddelen in combinatie met chemo- immunotherapie bij de behandeling van hooggradige gliomen.Vanaf1 aug 2012 → 31 dec 2016Financiering: IWT persoonsgebonden financ. - strategische onderzoeksbeurzen
Publicaties
1 - 10 van 14
- Tumor Targeting by Peptide-Decorated Gold Nanoparticles(2019)
Auteurs: Matthias Van Woensel
Pagina's: 2430 - 2444 - Histamine and T helper cytokine driven epithelial barrier dysfunction in allergic rhinitis(2018)
Auteurs: Brecht Steelant, Sven Seys, Laura Van Gerven, Matthias Van Woensel, Inge Kortekaas Krohn, Dominique Bullens, Karel Talavera Pérez, Guy Boeckxstaens, Jan Ceuppens, Peter Hellings
Pagina's: 951 - 963 - New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation(2018)
Auteurs: Matthias Van Woensel
Pagina's: 899 - 910 - Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth(2017)
Auteurs: Matthias Van Woensel, Joost Dejaegher, Ken Matsumoto, Petya Georgieva, Jochen Belmans, Raf Sciot, Max Mazzone, Steven De Vleeschouwer, Holger Gerhardt
Pagina's: 1629 - 1645 - Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy(2017)
Auteurs: Matthias Van Woensel, Abhishek Garg, Patrizia Agostinis, Jochen Belmans, Holger Gerhardt, Steven De Vleeschouwer
Pagina's: 1217 - Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing(2017)
Auteurs: Abhishek Garg, Lien Vandenberk, Matthias Van Woensel, Niels Vanthillo, Peter de Witte, Patrizia Agostinis
Pagina's: 832 - 843 - Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma(2017)
Auteurs: Abhishek Garg, Lien Vandenberk, Matthias Van Woensel, Jochen Belmans, Marco Schaaf, Steven De Vleeschouwer, Patrizia Agostinis
- Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes(2016)
Auteurs: Jeroen Plessers, Matthias Van Woensel, Dominique Bullens, Jef Pinxteren, Catherine Verfaillie
Pagina's: 1607 - 1619 - Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration(2016)
Auteurs: Matthias Van Woensel, Brecht Steelant, Stefaan Van Gool, Holger Gerhardt, Steven De Vleeschouwer
Pagina's: 71 - 81 - Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy(2016)
Auteurs: Matthias Van Woensel
Pagina's: 148 - 159
Patenten
1 - 3 van 3
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)